Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed MM

This study is ongoing, but not recruiting participants.

Study NCT00617591 Information provided by H. Lee Moffitt Cancer Center and Research Institute

First Received: February 5, 2008 Last Updated: November 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2012
Estimated Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)